Scientific and clinical evidence for Testosil
This hub centralizes available evidence: randomized controlled trials, observational cohorts, systematic reviews, and validated user feedback. It provides what you need to objectively assess Testosil’s efficacy and safety.
Analyzed clinical trials
| Study | Population | Duration | Key results | Link |
|---|---|---|---|---|
| Phase II – men 40–65 | n = 120, mild hypogonadism | 12 weeks | +22% total testosterone, −18% cortisol | Analysis |
| Endurance crossover study | n = 48, strength trainees | 8 weeks | +11% VO2max, +15% recovery | Analysis |
| Sleep observational cohort | n = 63, mild apnea | 16 weeks | +19% sleep quality, −14% fatigue | Analysis |
Verified testimonials
Medical FAQ
Is Testosil suitable for patients on TRT?
See Testosil vs TRT for co‑use recommendations and potential risks.
What biomarkers should be tracked during supplementation?
See the protocol guide: total/free testosterone, SHBG, cortisol, lipid profile.
Any contraindications?
Check the safety section of each ingredient brief and your physician’s guidance.
See each analysis for full references. Main references: Journal of Endocrinological Investigation 2024; European Journal of Sport Science 2023; EFSA meta‑analysis 2022.
